ScholarLens Back to search
2020•Kidney International ReportsOpen access

SAT-338 THE DILEMMA OF INDUCTION IMMUNOSUPPRESSION IN LOW IMMUNOLOGICAL RISK KIDNEY TRANSPLANT RECIPIENTS- A PROSPECTIVE RANDOMISED STUDY FROM EASTERN INDIA COMPARING BASILIXIMAB VERSUS NO INDUCTION IMMUNOSUPPRESSION

Varun Gosain, Chase Cavayero Sunny M Kar, Soumya P. Rout

Open full text 1 citations

Abstract

Induction immunosuppression decreases the risk for acute rejection and improves graft outcomes in kidney transplant recipients but in the current era of powerful maintenance immunosuppression, role of induction immunosuppression in low immunological risk group of patients is controversial. Hence, this was a suitable research question which was explored by us in an Indian setting. The objective of our study was to evaluate the impact of induction with basiliximab versus no induction therapy on outcomes in low immunological risk kidney transplant recipients (KTRs).

About this research paper

What this paper is about

Induction immunosuppression decreases the risk for acute rejection and improves graft outcomes in kidney transplant recipients but in the current era of powerful maintenance immunosuppression, role of induction immunosuppression in low immunological risk group of patients is controversial. Hence, this was a suitable research question which was explored by us in an Indian setting. The objective of our study was to evaluate the impact of induction with basiliximab versus no induction therapy on outcomes in low immunological risk kidney transplant recipients (KTRs).

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Induction immunosuppression decreases the risk for acute rejection and improves graft outcomes in kidney transplant recipients but in the current era of powerful maintenance immunosuppression, role of induction immunosuppression in low immunological risk group of patients is controversial. Hence, this was a suitable research question which was explored by us in an Indian setting. The objective of our study was to evaluate the impact of induction with basiliximab versus no induction therapy on outcomes in low immunological risk kidney transplant recipients (KTRs).

Key concepts: Immunosuppression, Basiliximab, Medicine, Kidney transplant, Kidney transplantation, Induction therapy, Immunology, Kidney

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
SAT-338 THE DILEMMA OF INDUCTION IMMUNOSUPPRESSION IN LOW IMMUNOLOGICAL RISK KIDNEY TRANSPLANT RECIPIENTS- A PROSPECTIVE RANDOMISED STUDY FROM EASTERN INDIA COMPARING BASILIXIMAB VERSUS NO INDUCTION IMMUNOSUPPRESSION — Research Paper | ScholarLens